Resources
Filter by Topic
- Press Releases
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to patient.
- Press Releases
Annual awards program recognizes outstanding products and companies that are disrupting healthcare
- Press Releases
United under Norstella, each brand’s key solutions and expertise will help life-sciences-focused companies get answers—not just insights—from pipeline to patient
- Articles
Chris Harvey and Carolyn Zele discuss the insights that health economics and outcomes research (HEOR) professionals bring to commercial teams. They explain how that pairing...
Pregnancy rates and outcomes in women with and without MS in the United States
Authors: MK Houtchens, NC Edwards, G Schneider, K Stern, AL Phillips Published: Neurology, 2018. Click here for the article.
Cost-effectiveness analysis of erenumab for the preventive treatment of episodic and chronic migraine: Results from the US societal and payer perspectives
Authors: Matthew Sussman, Jennifer Benner, Peter Neumann, Joseph Menzin Published: Cephalalgia, 2018. Click here for the full article.
Predictors of All-Cause Healthcare Payments Among Patients with Treatment-Resistant Major Depressive Disorder
Authors: M Sussman, A O’Sullivan, A Shah, J Menzin, M Olfson Published: Value in Health, ISPOR 2018 Click here for the article.
Real-World Bleeding Risks in Non-Valvular Atrial Fibrillation Patients with Heart Failure: Contemporary HER Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban, and Warfarin.
Authors: Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, and Gregory Y Lip Published: Circulation,
Comorbidity in US patients with multiple sclerosis
Authors: N Edwards, M Munsell, J Menzin, A Phillips Published: Patient Related Outcome Measures, 2018 Click here to view.
Development and validation of a claims-based measure as an indicator for disease severity in patients with multiple sclerosis treated with disease-modifying drugs
Authors: Michael Munsell, Molly Frean, Joseph Menzin, and Amy L. Phillips Published: BMC Neurology Click here for the article.
IHD Analytics
Put reliable, rapid analytics in the hands of more people across your organization